单孔胸腔镜肺段切除术治疗早期NSCLC患者肺功能及无瘤生存期的影响

奚雷, 侍烨, 崔伟明, 曹珲

湖南师范大学学报医学版 ›› 2023, Vol. 20 ›› Issue (6) : 108-112.

PDF(1952 KB)
PDF(1952 KB)
湖南师范大学学报医学版 ›› 2023, Vol. 20 ›› Issue (6) : 108-112.
临床医学

单孔胸腔镜肺段切除术治疗早期NSCLC患者肺功能及无瘤生存期的影响

  • 奚雷, 侍烨, 崔伟明, 曹珲
作者信息 +

Effect of single-port thoracoscopic segmentectomy on lung function, and disease free survival in patients with early NSCLC

  • XI Lei, SHI Ye, CUI Weiming, CAO Hui
Author information +
文章历史 +

摘要

目的:探究单孔胸腔镜肺段切除术治疗早期非小细胞肺癌(NSCLC)对患者肺功能、血清创伤反应和远期转移的影响。方法:从我院2020年4月—2021年9月期间收治的200例早期NSCLC患者中,使用计算机随机生成数字,将其分为对照组(100例)和观察组(100例)。对照组接受单孔胸腔镜肺叶切除手术,而观察组接受单孔胸腔镜肺段切除手术。比较两组患者手术情况,手术前后的肺功能指标[肺活量(FVC)、用力呼气一秒量(FEV1)以及FEV1/FVC]、血清指标中[前列腺素(PGE2)、皮质醇(Cor)和C反应蛋白(CRP)]的变化;比较两组患者癌胚抗原(CEA)、细胞角蛋白19片段(CYFRA21-1)和鳞状细胞癌抗原(SCC-Ag)的表达,并通过Kaplan-Meier曲线检验生存及远期转移情况;比较两组并发症发生情况。结果:观察组术中出血量较对照组少,手术持续时间较短而淋巴结清扫数目方面两组之间差异不显著;术后3个月,两组患者的肺功能参数FVC、FEV1和FEV1/FVC水平均较术前明显下降,但观察组的下降幅度相对较小,与对照组相比具有显著性差异;术后1个月,两组患者的血清PGE2、Cor和CRP水平均较术前明显升高,但观察组的升高幅度相对较小,与对照组相比具有显著性差异;两组CEA、CYFRA21-1和SCC-Ag均较术前显著降低,且观察组于对照组更低;术后两年随访显示,两组转移情况均较少,无瘤生存率两组没有显著差异;此外,两组并发症发生情况差异不显著。结论:单孔胸腔镜肺段切除术在治疗NSCLC相较于肺叶切除术能减轻创伤反应,维持肺功能,并降低肿瘤复发和转移风险。

Abstract

Objective To explore the effect of single-port thoracoscopic segmentectomy on lung function, serum trauma response and long-term metastasis in patients with early non-small cell lung cancer (NSCLC). Methods 200 patients with early NSCLC admitted to our hospital from April 2020 to September 2021 were divided into the control group (100 cases) and observation group (100 cases) by using a computer to randomly generate numbers. The control group received single-port thoracoscopic lobectomy while the observation group patients recceived single-port thoracoscopic segmentectomy. The surgical conditions of the two groups was compared, including lung function [forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and FEV1/FVC ratio], serum trauma response indicators [prostaglandin (PGE2), cortisol (Cor) and C-reactive protein (CRP) ] and tumor cell carcinoembryonic antigen (CEA), cytokeratin 19 fragment (CYFRA21-1) and squamous cell carcinoma antigen (SCC-Ag). The survival and long-term metastasis were tested by Kaplan-Meier curve, and the complications were compared. Results Compared with control group, the intraoperative blood loss in observation group was less and the surgical duration was shorter, but the number of lymph nodes dissection was not significantly different between the two groups. At 3 months after surgery, the lung function parameters FVC, FEV1 and FEV1/FVC in both groups were significantly decreased compared with those before surgery, but the decreases were relatively small in observation group, which had significant differences compared to control group. Serum levels of PGE2, Cor and CRP in the two groups at 1 month after surgery were significantly increased compared with those before surgery, but the increases in observation group were relatively small compared with those in control group. The levels of CEA, CYFRA21-1 and SCC-Ag in both groups was significantly reduced compared to before surgery, and the levels in observation group were lower than those in control group. At 2 years after surgery, metastasis was less in the two groups, and there was no significant difference in disease-free survival between the two groups. In addition, the complications revealed no obvious differences between the two groups. Conclusion Compared with lobectomy, single-port thoracoscopic segmentectomy in the treatment of NSCLC can better relieve the trauma response, maintain the lung function, and reduce the risk of tumor recurrence and metastasis.

关键词

单孔胸腔镜肺段切除术 / 非小细胞肺癌 / 肺功能 / 无瘤生存期

Key words

single-port thoracoscopic segmentectomy / non-small cell lung cancer / lung function / disease free survival

引用本文

导出引用
奚雷, 侍烨, 崔伟明, 曹珲. 单孔胸腔镜肺段切除术治疗早期NSCLC患者肺功能及无瘤生存期的影响[J]. 湖南师范大学学报医学版. 2023, 20(6): 108-112
XI Lei, SHI Ye, CUI Weiming, CAO Hui. Effect of single-port thoracoscopic segmentectomy on lung function, and disease free survival in patients with early NSCLC[J]. Journal of Hunan Normal University(Medical Science). 2023, 20(6): 108-112
中图分类号: R734.2   

参考文献

[1] 刘彦军. 早期非小细胞肺癌患者经单孔全胸腔镜解剖性肺段切除术治疗疗效评价[J]. 中国药物与临床, 2021, 21(11): 1921-1923.
[2] 万仁平, 廖洪亮, 易云峰. 完全胸腔镜下解剖性肺段切除与肺叶切除对非小细胞癌患者术后肺功能的影响[J]. 河北医药, 2018, 40(11): 1609-1612.
[3] 周跃, 袁双虎. 非小细胞肺癌纵隔淋巴结分期诊断研究进展[J]. 中华肿瘤防治杂志, 2017, 24(5): 344-349.
[4] LABABEDE O, MEZIANE MA.The Eighth Edition of TNM Staging of Lung Cancer: Reference Chart and Diagrams[J]. Oncologist, 2018, 23(7): 844-848.
[5] 张睿娟, 雷弋. 早期肺腺癌临床病理特征及分子特征研究进展[J]. 现代肿瘤医学, 2021, 29(23): 4246-4250.
[6] 梁启军, 杨玉萍, 李存霞. 非小细胞肺癌发病机制及中西医结合治疗路径再探析[J]. 中华中医药杂志, 2012, 27(5): 1355-1357.
[7] 李传俊, 罗燕, 吴晓涛, 等. 周围型非小细胞肺癌CT特征与EGFR基因突变的相关性研究[J]. 中国CT和MRI杂志, 2018, 16(8): 46-49.
[8] 王君, 张天赐, 魏大中. 单孔胸腔镜肺段切除术治疗肺结节118例[J]. 中国微创外科杂志, 2020, 20(11): 991-994.
[9] 张亚年, 张璐, 范心庭. 胸腔镜肺段切除术治疗非小细胞肺癌的临床效果及其对血清LDH、ProGRP、NSE的影响[J]. 临床和实验医学杂志, 2022, 21(19): 2062-2066.
[10] Zhang L.The Argument and Consensus of Lymphadenectomy on Lung Cancer Surgery[J]. Zhongguo Fei Ai Za Zhi, 2018, 21(3): 176-179.
[11] 李威, 郑中锋, 游锦智, 等. 不同入路单孔3D胸腔镜在Ⅰ-Ⅱ期非小细胞肺癌切除术中应用效果的对比研究[J]. 现代肿瘤医学, 2023, 31(1): 66-70.
[12] 田浩印, 李志娜, 李静, 等. 术前肺功能、术后sTREM-1、小野寺指数诊断NSCLC患者术后肺部感染的价值[J]. 标记免疫分析与临床, 2023, 30(2): 298-303.
[13] 马朝峰. 培美曲塞联合顺铂化疗对晚期非小细胞肺癌患者血清肿瘤标志物及KPS评分的影响[J]. 罕少疾病杂志, 2022, 29(4): 30-31.
[14] 杨宠裕. 瑞芬太尼复合丙泊酚麻醉对非小细胞肺癌根治术患者免疫功能及术后瞻妄的影响[J]. 医学临床研究, 2021, 38(3): 421-423+427.
[15] HAO C, ZHANG G, ZHANG L.Serum CEA levels in 49 different types of cancer and noncancer diseases[J]. Prog Mol Biol Transl Sci, 2019, 162: 213-227.
[16] DAL BELLO MG, FILIBERTI RA, ALAMA A, et al.The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients[J]. J Transl Med, 2019, 17(1): 74-78.
[17] ZHU B, DONG B, HONG S, et al.Combined Detection of ACTN4 and SCC-Ag is a Promising Serological Biomarker for Cervical Intraepithelial Neoplasia 3 or Worse: A Case-Control Study[J]. Risk Manag Healthc Policy, 2020, 13: 2677-2687.
[18] 方妙婵, 钟孟如, 张泳仪, 等. CRP、PCT、NC及NLR在非小细胞肺癌化疗后细菌感染诊断中的价值[J]. 川北医学院学报, 2023, 38(1): 32-35.
[19] 宋立强, 崔昊, 梁文全, 等. 早期胃癌伴淋巴结转移患者远期预后的影响因素分析[J]. 腹腔镜外科杂志, 2023, 28(1): 41-45.

基金

江苏省财政厅资助项目“ciR-0001811/MLIP通路参与矽肺炎症与纤维化的研究”(YY-118)

PDF(1952 KB)

Accesses

Citation

Detail

段落导航
相关文章

/